Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021


Report ID : RNR-44310 Category : Pharma Healthcare Published Date : Dec-16
Publisher : GlobalInfo Research Pages : 112 Format : PDF
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.

Scope of the Report:
This report focuses on the Active Pharmaceutical Ingredient in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy?s Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine
    Biocon
    Johnson Matthey
    Hisun Pharmacy
    Cambrex
    Shandong Xinhua Pharmaceutical
    Lonza group
    Huahai Pharmaceutical
    Haerbin Pharmaceutical Group
    Cipla
    Tian Yao
    Lupin
    North East Pharmaceutical
    Albemarle
    Shandong Lukang Pharmaceutical
    Jiangsu Hengrui Medicine
    Bachem

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
    Synthetic API
    Biotech API
    Other

Market Segment by Applications, can be divided into
    Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    Oncology Drugs
    Anti-diabetic Drugs
    Cardiovascular Drugs
    Central Nervous System Drugs (CNS Drugs)
    Musculoskeletal Drugs
    Other Drugs

There are 13 Chapters to deeply display the global Active Pharmaceutical Ingredient market.

Chapter 1, to describe Active Pharmaceutical Ingredient Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Active Pharmaceutical Ingredient, with sales, revenue, and price of Active Pharmaceutical Ingredient, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Active Pharmaceutical Ingredient, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Active Pharmaceutical Ingredient sales channel, distributors, traders, dealers, appendix and data source.
Table of Contents

Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021
1 Market Overview
    1.1 Active Pharmaceutical Ingredient Introduction
    1.2 Market Analysis by Type
        1.2.1 Synthetic API
        1.2.2 Biotech API
        1.2.3 Other
    1.3 Market Analysis by Applications
        1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        1.3.2 Oncology Drugs
        1.3.3 Anti-diabetic Drugs
    1.4 Market Analysis by Regions
        1.4.1 North America (USA, Canada and Mexico)
            1.4.1.1 USA
            1.4.1.2 Canada
            1.4.1.3 Mexico
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany
            1.4.2.2 France
            1.4.2.3 UK
            1.4.2.4 Russia
            1.4.2.5 Italy
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China
            1.4.3.2 Japan
            1.4.3.3 Korea
            1.4.3.4 India
            1.4.3.5 Southeast Asia
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil
            1.4.4.2 Egypt
            1.4.4.3 Saudi Arabia
            1.4.4.4 South Africa
            1.4.4.5 Nigeria
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Teva
        2.1.1 Business Overview
        2.1.2 Active Pharmaceutical Ingredient Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 Teva Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.2 Novartis
        2.2.1 Business Overview
        2.2.2 Active Pharmaceutical Ingredient Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Novartis Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.3 Pfizer
        2.3.1 Business Overview
        2.3.2 Active Pharmaceutical Ingredient Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.4 Johnson & Johnson
        2.4.1 Business Overview
        2.4.2 Active Pharmaceutical Ingredient Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.5 Mylan
        2.5.1 Business Overview
        2.5.2 Active Pharmaceutical Ingredient Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Mylan Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.6 North China Pharmaceutical Group
        2.6.1 Business Overview
        2.6.2 Active Pharmaceutical Ingredient Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.7 Dr. Reddy?s Laboratories
        2.7.1 Business Overview
        2.7.2 Active Pharmaceutical Ingredient Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 Dr. Reddy?s Laboratories Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.8 Roche
        2.8.1 Business Overview
        2.8.2 Active Pharmaceutical Ingredient Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Roche Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.9 Aurobindo pharma
        2.9.1 Business Overview
        2.9.2 Active Pharmaceutical Ingredient Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.10 Sun Pharmaceutical Industries
        2.10.1 Business Overview
        2.10.2 Active Pharmaceutical Ingredient Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.11 Boehringer Ingelheim GmbH
        2.11.1 Business Overview
        2.11.2 Active Pharmaceutical Ingredient Type and Applications
            2.11.2.1 Type 1
            2.11.2.2 Type 2
        2.11.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.12 Bayer
        2.12.1 Business Overview
        2.12.2 Active Pharmaceutical Ingredient Type and Applications
            2.12.2.1 Type 1
            2.12.2.2 Type 2
        2.12.3 Bayer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.13 BASF
        2.13.1 Business Overview
        2.13.2 Active Pharmaceutical Ingredient Type and Applications
            2.13.2.1 Type 1
            2.13.2.2 Type 2
        2.13.3 BASF Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.14 DSM
        2.14.1 Business Overview
        2.14.2 Active Pharmaceutical Ingredient Type and Applications
            2.14.2.1 Type 1
            2.14.2.2 Type 2
        2.14.3 DSM Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.15 Zhejiang Medicine
        2.15.1 Business Overview
        2.15.2 Active Pharmaceutical Ingredient Type and Applications
            2.15.2.1 Type 1
            2.15.2.2 Type 2
        2.15.3 Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.16 Biocon
        2.16.1 Business Overview
        2.16.2 Active Pharmaceutical Ingredient Type and Applications
            2.16.2.1 Type 1
            2.16.2.2 Type 2
        2.16.3 Biocon Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.17 Johnson Matthey
        2.17.1 Business Overview
        2.17.2 Active Pharmaceutical Ingredient Type and Applications
            2.17.2.1 Type 1
            2.17.2.2 Type 2
        2.17.3 Johnson Matthey Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.18 Hisun Pharmacy
        2.18.1 Business Overview
        2.18.2 Active Pharmaceutical Ingredient Type and Applications
            2.18.2.1 Type 1
            2.18.2.2 Type 2
        2.18.3 Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.19 Cambrex
        2.19.1 Business Overview
        2.19.2 Active Pharmaceutical Ingredient Type and Applications
            2.19.2.1 Type 1
            2.19.2.2 Type 2
        2.19.3 Cambrex Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.20 Shandong Xinhua Pharmaceutical
        2.20.1 Business Overview
        2.20.2 Active Pharmaceutical Ingredient Type and Applications
            2.20.2.1 Type 1
            2.20.2.2 Type 2
        2.20.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.21 Lonza group
        2.21.1 Business Overview
        2.21.2 Active Pharmaceutical Ingredient Type and Applications
            2.21.2.1 Type 1
            2.21.2.2 Type 2
        2.21.3 Lonza group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.22 Huahai Pharmaceutical
        2.22.1 Business Overview
        2.22.2 Active Pharmaceutical Ingredient Type and Applications
            2.22.2.1 Type 1
            2.22.2.2 Type 2
        2.22.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.23 Haerbin Pharmaceutical Group
        2.23.1 Business Overview
        2.23.2 Active Pharmaceutical Ingredient Type and Applications
            2.23.2.1 Type 1
            2.23.2.2 Type 2
        2.23.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.24 Cipla
        2.24.1 Business Overview
        2.24.2 Active Pharmaceutical Ingredient Type and Applications
            2.24.2.1 Type 1
            2.24.2.2 Type 2
        2.24.3 Cipla Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.25 Tian Yao
        2.25.1 Business Overview
        2.25.2 Active Pharmaceutical Ingredient Type and Applications
            2.25.2.1 Type 1
            2.25.2.2 Type 2
        2.25.3 Tian Yao Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.26 Lupin
        2.26.1 Business Overview
        2.26.2 Active Pharmaceutical Ingredient Type and Applications
            2.26.2.1 Type 1
            2.26.2.2 Type 2
        2.26.3 Lupin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.27 North East Pharmaceutical
        2.27.1 Business Overview
        2.27.2 Active Pharmaceutical Ingredient Type and Applications
            2.27.2.1 Type 1
            2.27.2.2 Type 2
        2.27.3 North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.28 Albemarle
        2.28.1 Business Overview
        2.28.2 Active Pharmaceutical Ingredient Type and Applications
            2.28.2.1 Type 1
            2.28.2.2 Type 2
        2.28.3 Albemarle Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.29 Shandong Lukang Pharmaceutical
        2.29.1 Business Overview
        2.29.2 Active Pharmaceutical Ingredient Type and Applications
            2.29.2.1 Type 1
            2.29.2.2 Type 2
        2.29.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.30 Jiangsu Hengrui Medicine
        2.30.1 Business Overview
        2.30.2 Active Pharmaceutical Ingredient Type and Applications
            2.30.2.1 Type 1
            2.30.2.2 Type 2
        2.30.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
    2.31 Bachem
        2.31.1 Business Overview
        2.31.2 Active Pharmaceutical Ingredient Type and Applications
            2.31.2.1 Type 1
            2.31.2.2 Type 2
        2.31.3 Bachem Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share
3 Global Active Pharmaceutical Ingredient Market Competition, by Manufacturer
    3.1 Global Active Pharmaceutical Ingredient Sales and Market Share by Manufacturer
    3.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Manufacturer
    3.3 Market Concentration Rate
        3.3.1 Top 3 Active Pharmaceutical Ingredient Manufacturer Market Share
        3.3.2 Top 6 Active Pharmaceutical Ingredient Manufacturer Market Share
    3.4 Market Competition Trend
4 Global Active Pharmaceutical Ingredient Market Analysis by Regions
    4.1 Global Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
        4.1.1 Global Active Pharmaceutical Ingredient Sales by Regions (2011-2016)
        4.1.2 Global Active Pharmaceutical Ingredient Revenue by Regions (2011-2016)
    4.2 North America Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    4.3 Europe Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    4.4 Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    4.5 South America Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    4.6 Middle East and Africa Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
5 North America Active Pharmaceutical Ingredient by Countries
    5.1 North America Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
        5.1.1 North America Active Pharmaceutical Ingredient Sales by Countries (2011-2016)
        5.1.2 North America Active Pharmaceutical Ingredient Revenue by Countries (2011-2016)
    5.2 USA Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    5.3 Canada Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    5.4 Mexico Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
6 Europe Active Pharmaceutical Ingredient by Countries
    6.1 Europe Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
        6.1.1 Europe Active Pharmaceutical Ingredient Sales by Countries (2011-2016)
        6.1.2 Europe Active Pharmaceutical Ingredient Revenue by Countries (2011-2016)
    6.2 Germany Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    6.3 UK Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    6.4 France Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    6.5 Russia Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    6.6 Italy Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
7 Asia-Pacific Active Pharmaceutical Ingredient by Countries
    7.1 Asia-Pacific Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Active Pharmaceutical Ingredient Sales by Countries (2011-2016)
        7.1.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue by Countries (2011-2016)
    7.2 China Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    7.3 Japan Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    7.4 Korea Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    7.5 India Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    7.6 Southeast Asia Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
8 South America, Middle East and Africa Active Pharmaceutical Ingredient by Countries
    8.1 South America, Middle East and Africa Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Countries
        8.1.1 South America, Middle East and Africa Active Pharmaceutical Ingredient Sales by Countries (2011-2016)
        8.1.2 South America, Middle East and Africa Active Pharmaceutical Ingredient Revenue by Countries (2011-2016)
    8.2 Brazil Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    8.3 Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    8.4 Egypt Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    8.5 Nigeria Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
    8.6 South Africa Active Pharmaceutical Ingredient Sales and Growth (2011-2016)
9 Active Pharmaceut